Journal of Lipid Research, Vol. 23, 1224-1235, November 1982
Copyright © 1982 by Lipid Research, Inc.

Studies of familial type III hyperlipoproteinemia using as a genetic marker the apoE phenotype E2/2

Jan L. Breslow , Vassilis I. Zannis , Thomas R. SanGiacomo , Jane L. H. C. Third , Trent Tracy , and Charles J. Glueck

Metabolism Division, Children's Hospital Medical Center, and the Department of Pediatrics, Harvard Medical School, Boston, MA 02115, and Lipid Research Clinic, General Clinical Research and CLINFO Centers, Department of Medicine, Lipid Research Division, University of Cincinnati College of Medicine, Cincinnati, OH 45267

Clinical symptoms, lipoprotein patterns, and apoE phenotypes were determined in 17 individuals with type III hyperlipoproteinemia (type III HLP) and in their relatives and spouses. The apoE phenotype E2/2 occurred in 15 type III HLP probands (88%) and the apoE phenotype E4/2 was found in 2 probands. In each of the families studied, the apoE phenotype inheritance was compatible with a model we previously proposed in which apoE is determined at a single genetic locus with three common alleles. The apoE phenotypes E4/4, E3/3, and E2/2 represent homozygosity for the apoE alleles 4, 3, and 2, respectively, whereas the apoE phenotypes E4/3, E3/2, and E4/2 represent heterozygosity for the apoE alleles 4/3, 3/2, and 4/2, respectively. Plasma lipids in 69 relatives of type III HLP probands were analyzed by apoE phenotype and revealed no significant differences between phenotypes in the levels of cholesterol, triglyceride, or HDL cholesterol. However, there were differences between the apoE phenotypes in LDL cholesterol levels (P = 0.01) and in the ratio of VLDL cholesterol/total triglyceride (ratio) (P < 0.01). Relatives with the apoE phenotype E2/2 had the lowest LDL cholesterol levels and the highest ratios. Of these eleven individuals with the apoE phenotype E2/2 who were not type III HLP probands, two males were taking lipid-lowering drugs, one male had mild angina at age 59, five individuals had ratios >0.25 and two had ratios >0.30 with the ratios for males (0.28 ± 0.06) significantly greater than the ratios for females (0.17 ± 0.06) (P < 0.01), and seven had evidence of floating ßbeta;VLDL on lipoprotein electrophoresis. In addition, when compared to a control group in the general population, the whole group of relatives had normal cholesterol and HDL cholesterol levels, slightly low LDL cholesterol levels, and almost twice elevated triglyceride levels. In summary, a) a very strong but not invariate association exists between type III HLP and the apoE phenotype E2/2 with some type III HLP individuals having the apoE phenotype E4/2; b) apoE phenotype inheritance is determined by three alleles at a single genetic locus; c) relatives of type III HLP probands, no matter what their apoE phenotype, have on the average nearly twofold elevated plasma triglyceride levels compared to a control population; and d) non-proband type III HLP individuals with the apoE phenotype E2/2 have been identified. As a group these individuals, particularly the males, show a tendency to express type III HLP, but clearly genetic or environmental factors other than the apoE phenotype E2/2 are required for the full phenotypic expression of this disease.—Breslow, J. L., V. I. Zannis, T. R. SanGiacomo, J. L. H. C. Third, T. Tracy, and C. J. Glueck. Studies of familial type III hyperlipoproteinemia using as a genetic marker the apoE phenotype E2/2.

Supplementary key words apoE phenotype • LDL • plasma triglycerides • plasma cholesterol • ßbeta;VLDL

Submitted on February 4, 1982
Revised on June 4, 1982

CiteULike    Complore    Connotea    Del.icio.us    Digg    Reddit    Technorati    What's this?

This article has been cited by other articles:

				M. Wyler von Ballmoos, D. Dubler, M. Mirlacher, G. Cathomas, J. Muser, and B. C. Biedermann Increased Apolipoprotein Deposits in Early Atherosclerotic Lesions Distinguish Symptomatic From Asymptomatic Patients Arterioscler. Thromb. Vasc. Biol., February 1, 2006; 26(2): 359 - 364. [Abstract] [Full Text] [PDF]

				N. Ghebranious, L. Ivacic, J. Mallum, and C. Dokken Detection of ApoE E2, E3 and E4 alleles using MALDI-TOF mass spectrometry and the homogeneous mass-extend technology Nucleic Acids Res., October 4, 2005; 33(17): e149 - e149. [Abstract] [Full Text] [PDF]

				C Aucan, A J Walley, and A V S Hill Common apolipoprotein E polymorphisms and risk of clinical malaria in the Gambia J. Med. Genet., January 1, 2004; 41(1): 21 - 24. [Full Text] [PDF]

				G. Gerritsen, K. E. Kypreos, A. van der Zee, B. Teusink, V. I. Zannis, L. M. Havekes, and K. W. van Dijk Hyperlipidemia in APOE2 transgenic mice is ameliorated by a truncated apoE variant lacking the C-terminal domain J. Lipid Res., February 1, 2003; 44(2): 408 - 414. [Abstract] [Full Text] [PDF]

				Gianluca De Bellis, G. Salani, S. Panigone, F. Betti, L. Invernizzi, and M. Luzzana Apolipoprotein E genotyping by capillary electrophoretic analysis of restriction fragments Clin. Chem., August 1, 1997; 43(8): 1321 - 1324. [Abstract] [Full Text] [PDF]